Geulah Livshits
Stock Analyst at Chardan Capital
(1.85)
# 3,104
Out of 4,757 analysts
174
Total ratings
27.11%
Success rate
-5.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FDMT 4D Molecular Therapeutics | Maintains: Buy | $39 → $30 | $4.55 | +559.34% | 7 | Feb 11, 2025 | |
CRGX CARGO Therapeutics | Downgrades: Neutral | n/a | $3.59 | - | 3 | Jan 30, 2025 | |
IMRX Immuneering | Maintains: Buy | $13 | $1.82 | +614.29% | 9 | Jan 8, 2025 | |
KRYS Krystal Biotech | Maintains: Buy | $212 | $151.32 | +40.10% | 8 | Dec 18, 2024 | |
TNYA Tenaya Therapeutics | Maintains: Buy | $18 | $0.90 | +1,905.57% | 9 | Dec 18, 2024 | |
EDIT Editas Medicine | Downgrades: Neutral | n/a | $1.19 | - | 10 | Dec 13, 2024 | |
CRSP CRISPR Therapeutics AG | Maintains: Buy | $94 | $43.30 | +117.09% | 11 | Dec 10, 2024 | |
SNTI Senti Biosciences | Maintains: Buy | $10 → $12 | $4.05 | +196.30% | 7 | Dec 4, 2024 | |
MGX Metagenomi | Maintains: Buy | $15 | $2.39 | +527.62% | 5 | Nov 20, 2024 | |
RCKT Rocket Pharmaceuticals | Maintains: Buy | $62 | $9.86 | +528.80% | 14 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $91 | $9.51 | +856.89% | 12 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $0.52 | +1,247.97% | 3 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.60 | +337.50% | 11 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $2.55 | +488.24% | 2 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $3.95 | +532.91% | 6 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $3.53 | +324.93% | 4 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $11 | $0.75 | +1,371.18% | 4 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $1.38 | +334.78% | 5 | Apr 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $5.34 | +536.70% | 10 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $6.44 | +536.65% | 4 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $5.07 | +393.10% | 2 | Mar 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.48 | +383.87% | 4 | Mar 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $30.54 | +581.19% | 7 | Jan 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.28 | +1,150.00% | 4 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $2.5 | $7.95 | -68.55% | 5 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $7.20 | +1,150.00% | 1 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $4.42 | -9.50% | 3 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $660 → $600 | $1.25 | +47,900.00% | 2 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $4.09 | +633.50% | 1 | Jul 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $10.40 | +73.08% | 1 | Oct 27, 2020 |
4D Molecular Therapeutics
Feb 11, 2025
Maintains: Buy
Price Target: $39 → $30
Current: $4.55
Upside: +559.34%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.59
Upside: -
Immuneering
Jan 8, 2025
Maintains: Buy
Price Target: $13
Current: $1.82
Upside: +614.29%
Krystal Biotech
Dec 18, 2024
Maintains: Buy
Price Target: $212
Current: $151.32
Upside: +40.10%
Tenaya Therapeutics
Dec 18, 2024
Maintains: Buy
Price Target: $18
Current: $0.90
Upside: +1,905.57%
Editas Medicine
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
CRISPR Therapeutics AG
Dec 10, 2024
Maintains: Buy
Price Target: $94
Current: $43.30
Upside: +117.09%
Senti Biosciences
Dec 4, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $4.05
Upside: +196.30%
Metagenomi
Nov 20, 2024
Maintains: Buy
Price Target: $15
Current: $2.39
Upside: +527.62%
Rocket Pharmaceuticals
Nov 18, 2024
Maintains: Buy
Price Target: $62
Current: $9.86
Upside: +528.80%
Nov 18, 2024
Maintains: Buy
Price Target: $88 → $91
Current: $9.51
Upside: +856.89%
Nov 14, 2024
Maintains: Buy
Price Target: $7
Current: $0.52
Upside: +1,247.97%
Nov 14, 2024
Maintains: Buy
Price Target: $7
Current: $1.60
Upside: +337.50%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $2.55
Upside: +488.24%
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $25
Current: $3.95
Upside: +532.91%
Nov 11, 2024
Maintains: Buy
Price Target: $15
Current: $3.53
Upside: +324.93%
Nov 7, 2024
Maintains: Buy
Price Target: $17 → $11
Current: $0.75
Upside: +1,371.18%
Apr 5, 2024
Maintains: Buy
Price Target: $11 → $6
Current: $1.38
Upside: +334.78%
Feb 20, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $5.34
Upside: +536.70%
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $6.44
Upside: +536.65%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $5.07
Upside: +393.10%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $2.48
Upside: +383.87%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $30.54
Upside: +581.19%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $1.28
Upside: +1,150.00%
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $7.95
Upside: -68.55%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $7.20
Upside: +1,150.00%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $4.42
Upside: -9.50%
Aug 13, 2021
Maintains: Buy
Price Target: $660 → $600
Current: $1.25
Upside: +47,900.00%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $4.09
Upside: +633.50%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $10.40
Upside: +73.08%